Front > HEALTHCARE

HEALTHCARE

Healthee team credit: Healthee PR AI healthcare costs management co Healthee raises $50m

Healthee’s benefits and care navigation platform empowers employees and employers to make the most of their health benefits.

Roy Goldenberg  credit: Jonathan Bloom Making a better world for the disabled

Personal experience motivated Roy Goldenberg to become Israel director of TOM Tikkun Olam Makers. "TOM will be one of the biggest organizations to come out of Israel," he says.

Dr. Adi Tzoref-Lorenz credit: Jonathan Bloom "My research says I don't accept there is no answer"

The death of a cancer patient spurred Dr. Adi Zoref-Lorenz into developing the OHI index, which allows the diagnosis of the HLH side effect from cancer immunotherapy, based on two blood tests.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Navina founders Ronen Lavi and Shay Perera credit: Eyal Izhar Israeli clinical AI co Navina raises $55m

Navina equips clinicians and care teams with real-time, data-driven insights that improve the quality of care and financial outcomes.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Dangoor Academy  credit: British Embassy in Tel Aviv British Embassy showcases Israeli healthcare startups

The nine startups participated in the Dangoor HealthTech Academy, a program that connects Israeli startups with the UK healthcare system.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Peter Kash credit: personal photograph Peter Kash confident about cancer cure breakthrough

In Israel for IATI's MIXiii International Life Science and Health-Tech week, the US investor talks about his life science portfolio and the opportunities Israel must seize.

IATA CEO Karin Mayer Rubinstein credit: Michael Franco IATI optimistic life sciences recovery will continue

85% of the senior figures in venture capital funds in Israel's biomed sector see investments by companies and foreign funds increasing in 2025 compared with 2024.

Medical research  credit: Shutterstock Boston Scientific buys Israeli medical device co SoniVie

The US medical device company will pay up to $540 million for the Rehovot-based intravascular ultrasound device developer for treating high blood pressure.

Sheba, Tel Hashomer Hospital Photo: Tamar Matsafi Israel's Sheba climbs in "Newsweek" world hospital top ten

Last year "Newsweek" ranked Sheba Medical Center in ninth place and previously it was in tenth place.

Teva CEO Richard Francis credit: Elad Malka Teva CEO responds to 25% share price fall

Richard Francis said that the question is no longer whether Teva will survive but whether it can grow more.

Teva CEO Richard Francis credit: Sivan Faraj Teva files to raise first capital since 2016

The Israeli pharmaceutical company's debt fell to $17.8 billion at the end of 2024, down from $19.8 billion at the end of the 2023.

flo Optics team credit: PR Optical lens digital printing co flo Optics raises $35m

The Israeli company aims to disrupt the optical industry by digitalizing the lens coating process.

Richard Francis  credit: PR Analysts remain positive on Teva

The company's 2025 guidance sent its share price tumbling, but analysts stress its investment in its innovative pipeline and debt reduction.

Teva CEO Richard Francis credit: Elad Malka Teva falls sharply on disappointing 2025 guidance

The Israeli pharmaceuticals company reported strong fourth quarter results but its 2025 outlook did not meet expectations.

Tal Zaks credit: Dani Machlis Tal Zaks's Israeli startup targets rare genetic diseases

The former Moderna CMO, who led development of the company's Covid vaccine, tells "Globes" about Averna Therapeutics, which through gene editing is developing groundbreaking drugs.

Eleos founders credit: Omri Miron Israeli AI mental healthcare co Eleos raises $60m

The company is also announcing the launch of a powerful new clinical documentation improvement (CDI) product, Eleos Compliance.

Amir Gal-Or credit: Koby Kantor OMGene.AI: Using DNA and AI to identify our strengths

Veteran Israeli venture capitalist Amir Gal-Or is launching an ambitious AI-enabled system that will produce personalized DNA-based recommendations.

Medical cannabis credit: Shutterstock Is medical cannabis effective in treating PTSD?

The medical controversy on the matter in Israel exposes the problem of obtaining accurate clinical data on the effectiveness of medical cannabis for treating all conditions.

EndoStream founders Alon May and Danel Mayer credit: Elad Naftali Japan's Kaneka buys Israeli co EndoStream Medical

The Or Akiva-based medical device company is developing the Nautilus device for aneurysm treatment.

Richard Francis and Avishai Abrahami credit: Elad Malkah and Alan Tzatzkin US analysts list Teva, Wix in 2025 top picks

Bank of America has raised Teva's price target to $26 per share and Cantor Fitzgerald has raised Wix's price target to $260 per share.

Tzahi Hagag  credit: Tamar Matsafi Cannabis co InterCure raising NIS 66m for Nir Oz facility

Yaron Yakobi and Tzahi Hagag will become parties at interest in the company led by Ehud Barak and Alexander Rabinovich. ,

Teva CEO Richard Francis credit: Teva Spokesperson Teva share price at 6-year high after trial results

The Israeli pharmaceutical company's market cap gained $5 billion in one Wall Street session boosting Israeli pension funds by hundreds of millions of dollars.

Teva  credit: Cineberg/Shutterstock Teva jumps sharply on bowel disease drug results

Teva reported that the trial for Dukaviyug, which it is developing with Sanofi, met its endpoints in ulcerative colitis and Crohn's disease.

Architects chosen for new Negev hospital

The winning firm is Rubinstein Ofer with Canadian architects Tye Farrow.

Michal Tsur at the Isreal Business Conference  credit: Cadya Levy "The best Parkinson's medication will be Israeli, and hybrid"

Remepy co-founder Michal Tsur told the Israel Business Conference about the therapy revolution whose time has come.

Twitter Facebook Linkedin RSS Newsletters âìåáñ Israel Business Conference 2018